Colin J.D. Ross

ORCID: 0000-0003-1476-7037
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmacogenetics and Drug Metabolism
  • Electron Spin Resonance Studies
  • Pharmaceutical studies and practices
  • Cancer therapeutics and mechanisms
  • Pharmacological Effects and Toxicity Studies
  • Metabolism and Genetic Disorders
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Childhood Cancer Survivors' Quality of Life
  • Diabetes and associated disorders
  • Lipid metabolism and disorders
  • Virus-based gene therapy research
  • Genomics and Rare Diseases
  • Molecular Sensors and Ion Detection
  • PARP inhibition in cancer therapy
  • Acute Lymphoblastic Leukemia research
  • Lung Cancer Research Studies
  • Pancreatic function and diabetes
  • Mitochondrial Function and Pathology
  • CRISPR and Genetic Engineering
  • Genetics and Neurodevelopmental Disorders
  • Hearing, Cochlea, Tinnitus, Genetics
  • Chemotherapy-induced organ toxicity mitigation
  • Genetic Neurodegenerative Diseases
  • RNA regulation and disease
  • Maternal Mental Health During Pregnancy and Postpartum

British Columbia Children's Hospital
2016-2025

University of British Columbia
2016-2025

Translational Therapeutics (United States)
2012-2024

St. Paul's Hospital
2024

Université de Montréal
2023

University of British Columbia Hospital
2010-2023

Innovative Medicines Canada
2023

National University of Singapore
2019-2020

Pharmaceutical Biotechnology (Czechia)
2019-2020

University of Florida
2019

In 2009 we reported the fatal case of a toddler who had received codeine after adenotonsillectomy for obstructive sleep apnea syndrome. The child was an ultra-rapid metabolizer cytochrome P4502D6 (CYP2D6). We now report 3 additional or life-threatening cases from North America. 2 cases, functional gene duplications encoding CYP2D6 caused significantly greater production potent morphine its parent drug, codeine. A severe respiratory depression in extensive is also noted. These demonstrate...

10.1542/peds.2011-2538 article EN PEDIATRICS 2012-04-10

Anthracycline-induced cardiotoxicity (ACT) is a serious adverse drug reaction limiting anthracycline use and causing substantial morbidity mortality. Our aim was to identify genetic variants associated with ACT in patients treated for childhood cancer.We carried out study of 2,977 single-nucleotide polymorphisms (SNPs) 220 key biotransformation genes discovery cohort 156 anthracycline-treated children from British Columbia, replication second 188 across Canada further the top SNP third 96...

10.1200/jco.2010.34.3467 article EN Journal of Clinical Oncology 2011-09-07

A large number of women receive codeine for obstetric pain while breastfeeding. Following a case fatal opioid poisoning in breastfed neonate whose prescribed mother was CYP2D6 ultrarapid metabolizer (UM), we examined characteristics mothers and infants with or without signs central nervous system (CNS) depression following exposure breastfeeding case–control study. Mothers symptomatic (n = 17) consumed mean 59% higher dose than asymptomatic 55) (1.62 (0.79) mg/kg/day vs. 1.02 (0.54)...

10.1038/clpt.2008.157 article EN Clinical Pharmacology & Therapeutics 2008-08-20

Abstract A Saskatchewan multi-incident family was clinically characterized with Parkinson disease (PD) and Lewy body pathology. PD segregates as an autosomal-dominant trait, which could not be ascribed to any known mutation. DNA from three affected members subjected exome sequencing. Genome alignment, variant annotation comparative analyses were used identify shared coding mutations. Sanger sequencing performed within the extended ethnically matched controls. Subsequent genotyping in a...

10.1093/hmg/ddt570 article EN Human Molecular Genetics 2013-11-11

Whole-exome sequencing has transformed gene discovery and diagnosis in rare diseases. Translation into disease-modifying treatments is challenging, particularly for intellectual developmental disorder. However, the exception inborn errors of metabolism, since many these disorders are responsive to therapy that targets pathophysiological features at molecular or cellular level.To uncover genetic basis potentially treatable we combined deep clinical phenotyping (the comprehensive...

10.1056/nejmoa1515792 article EN New England Journal of Medicine 2016-05-25
Folefac Aminkeng Amit P. Bhavsar Henk Visscher Shahrad R. Rassekh Yuling Li and 95 more Jong Wook Lee Liam R. Brunham Huib N. Caron Elvira C van Dalen Leontien C.M. Kremer Helena J. H. van der Pal Ursula Amstutz Michael Rieder Daniel Bernstein Bruce Carleton Michael R. Hayden Colin J.D. Ross Michael R. Hayden Bruce Carleton Colin J.D. Ross Stuart MacLeod Anne Smith Claudette Hildebrand Reza Ghannadan Shahrad R. Rassekh Henk Visscher Folefac Aminkeng Fudan Miao Michelle Higginson Nasim Massah Adrienne E. Borrie Ursula Amstutz Shevaun Hughes Kaitlyn Shaw Satvir Dhoot Amit P. Bhavsar Yuling Li Jong Wook Lee Kaarina Kowalec Jessica Stortz Tessa Bendyshe-Walton Duncan Waltrip Rachel Bader Cheri Nijssen–Jordan David W. Johnson Linda Verbeek Rick Kaczowka Patti Stevenson Carnation Zhuwaki Paul Grundy Kent Stobart Bev Wilson Sunil Desai Maria Spavor L. J. C. Churcher Terence Chow Kevin Hall Nick Honcharik Sara J. Israels Shanna Chan Byron Garnham Michelle Staub Geert ‘t Jong Michael Rieder Becky Malkin Carol Portwine Amy Cranston Gideon Koren Shinya Ito Paul C. Nathan Mark Greenberg Facundo García‐Bournissen Miho Inoue Sachi Sakaguchi Toshihiro Tanaka Hisaki Fujii Mina Ogawa Ryoko Ingram Taro Kamiya Smita Karande Sholeh Ghayoori Mariana Silva Stephanie Willing Régis Vaillancourt Donna L. Johnston Herpreet Mankoo Elaine Wong Brenda Wilson Lauren O’Connor Caleb Hui Cindy Yuen Jean‐François Bussières Denis Lebel Pierre Barret Aurélie Clauson Ève Courbon L. Cerruti Nada Jabado Anelise Espirito Santo M. CHRISTINE NAGY

10.1038/ng.3374 article EN Nature Genetics 2015-08-03

The objectives of the present study were to evaluate impact a single bout high-intensity aerobic exercise on 1) long-term potentiation (LTP)-like neuroplasticity via response paired associative stimulation (PAS) and 2) temporal spatial components sequence-specific implicit motor learning. Additionally, relationships between exercise-induced increases in systemic brain-derived neurotrophic factor (BDNF) PAS learning evaluated. Sixteen young healthy participants completed six experimental...

10.1152/japplphysiol.00498.2014 article EN Journal of Applied Physiology 2014-09-26

Statins reduce cardiovascular morbidity and mortality in appropriately selected patients. However, statin-associated myopathy is a significant risk associated with these agents. Recently, variation the SLCO1B1 gene was reported to predict simvastatin-associated myopathy. The aim of this study replicate association rs4149056 variant severe cohort patients using variety statin medications investigate specific types. We identified 25 cases 84 controls matched for age, gender, type dose. not...

10.1038/tpj.2010.92 article EN cc-by-nc-nd The Pharmacogenomics Journal 2011-01-18

Abstract Background . The use of anthracyclines as effective antineoplastic drugs is limited by the occurrence cardiotoxicity. Multiple genetic variants predictive anthracycline‐induced cardiotoxicity (ACT) in children were recently identified. current study was aimed to assess replication these findings an independent cohort children. Procedure Twenty‐three tested for association with ACT 218 patients. Predictive models including and clinical risk factors constructed original assessed...

10.1002/pbc.24505 article EN Pediatric Blood & Cancer 2013-02-25

We undertook genetic analysis of three affected families to identify the cause dominantly-inherited CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorineural hearing loss) syndrome. used whole-exome sequencing analyze two with syndrome, including original family reported in 1996, Sanger assess familial segregation rare variants identified probands a third, apparently unrelated found an identical heterozygous missense mutation, c.2452G > A (p.(Glu818Lys)), Na+/K+ ATPase...

10.1186/1750-1172-9-15 article EN cc-by Orphanet Journal of Rare Diseases 2014-01-01

To investigate whether prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure affects behavior in 3-year-olds of antenatally anxious or depressed mothers and risk was moderated by the transporter promoter (SLC6A4) genotype.Prospective longitudinal cohort design.Vancouver.Mothers their 3-year-old children (n = 33 SSRI exposed n 42 nonexposed). Main Exposures Prenatal to antidepressants postnatal maternal mood disturbances.Parent report child (Child Behavior Checklist,...

10.1001/archpediatrics.2010.51 article EN Archives of Pediatrics and Adolescent Medicine 2010-05-01

Cisplatin is a widely used chemotherapeutic agent for the treatment of solid tumors. A serious complication cisplatin permanent hearing loss. The aim this study was to replicate previous genetic findings in an independent cohort 155 pediatric patients. Associations were replicated variants TPMT (rs12201199, P = 0.0013, odds ratio (OR) 6.1) and ABCC3 (rs1051640, 0.036, OR 1.8). predictive model combining TPMT, ABCC3, COMT with clinical variables (patient age, vincristine treatment, germ-cell...

10.1038/clpt.2013.80 article EN Clinical Pharmacology & Therapeutics 2013-04-10

The occurrence of hypersensitivity reactions including rare but life-threatening Stevens–Johnson syndrome (SJS) and drug-induced (HSS) limits the use anticonvulsant carbamazepine (CBZ). Human leukocyte antigen-B (HLA)-B*15:02 HLA-A*31:01 have been identified as predictive genetic markers for CBZ in Asian European patients. To replicate these associations pediatric patients from North America with a diverse ethnic background, we investigated HLA-B*15:02 42 children 91 CBZ-tolerant across...

10.1038/clpt.2013.55 article EN Clinical Pharmacology & Therapeutics 2013-03-18

Aim: To identify novel variants associated with anthracycline-induced cardiotoxicity and to assess these in a genotype-guided risk prediction model. Patients & methods: Two cohorts treated for childhood cancer (n = 344 218, respectively) were genotyped 4578 SNPs drug ADME toxicity genes. Results: Significant associations identified SLC22A17 (rs4982753; p 0.0078) SLC22A7 (rs4149178; 0.0034), replication the second cohort (p 0.0071 0.047, respectively). Additional evidence was found SULT2B1...

10.2217/pgs.15.61 article EN Pharmacogenomics 2015-07-01
Coming Soon ...